Text Size

Frequency Analysis of Coronary Artery Disease

This study is currently recruiting participants.
Verified February 2013 by University of Minnesota - Clinical and Translational Science Institute
Sponsor:
Information provided by (Responsible Party):
University of Minnesota - Clinical and Translational Science Institute
ClinicalTrials.gov Identifier:
NCT01043237
First received: January 4, 2010
Last updated: February 27, 2013
Last verified: February 2013
History of Changes
  Purpose

The purpose of this study is to determine if coronary artery disease can be detected using an electronic, acoustic recording instrument. The presence or absence of abnormal pathology will be confirmed by diagnostic angiography as part of the normal patient care at this institution.


Condition
Coronary Artery Disease

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: A Single-centered Investigation Into the Frequency Domain Patterns in Vessels of Patients With Coronary Artery Disease

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by University of Minnesota - Clinical and Translational Science Institute:

Primary Outcome Measures:
  • to determine if coronary artery disease can be detected using an electronic, acoustic recording instrument [ Time Frame: Baselin ] [ Designated as safety issue: No ]
    to determine if coronary artery disease can be detected using an electronic, acoustic recording instrument


Estimated Enrollment: 330
Study Start Date: March 2009
Estimated Study Completion Date: March 2013
Estimated Primary Completion Date: March 2013 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years to 89 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patients presenting to the University of Minnesota Medical Center (UMMC) Fairview Clinics, Physicians (UMP) or the Redwing, Minnesota clinic

Criteria

Inclusion Criteria:

  • Patients aged 18-89 years old and recommended for a cardiology related angiogram within 24 hours

Exclusion Criteria:

  • Any patient less than 18 years of age or greater than 89 years of age.
  • Any patient with any of the following conditions: pregnant or nursing, prior myocardial infarction, left ventricular device, heart transplant, valve replacement, congestive heart failure, atrial fibrillation (non-intermittent), endocarditis or any heart viral or bacterial infection, any patient who has or requires medication or other heart rhythm altering treatment.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01043237

Contacts
Contact: Robert Wilson, MD 6126257617

Locations
United States, Minnesota
University of Minnesota Medical Center (UMMC) Fairview Clinics Recruiting
Minneapolis, Minnesota, United States, 55455
Contact: Robert Wilson, MD     612-626-7617        
Principal Investigator: Robert Wilson, MD            
Sponsors and Collaborators
University of Minnesota - Clinical and Translational Science Institute
Investigators
Principal Investigator: Robert Wilson, MD University of Minnesota - Clinical and Translational Science Institute
  More Information

No publications provided

Responsible Party: University of Minnesota - Clinical and Translational Science Institute
ClinicalTrials.gov Identifier: NCT01043237     History of Changes
Other Study ID Numbers: 0901M57884
Study First Received: January 4, 2010
Last Updated: February 27, 2013
Health Authority: United States: Institutional Review Board

Keywords provided by University of Minnesota - Clinical and Translational Science Institute:
acoustic
digital
sound
vibration
 coronary
auscultation
artery
diagnosis

Additional relevant MeSH terms:
Coronary Artery Disease
Myocardial Ischemia
Coronary Disease
Heart Diseases
 Cardiovascular Diseases
Arteriosclerosis
Arterial Occlusive Diseases
Vascular Diseases

ClinicalTrials.gov processed this record on May 21, 2013